Cdcl 009 [updated] ⭐ Must Watch

| Parameter | IV | PO | | :--- | :--- | :--- | | CL (mL/min/kg) | 18 | - | | Vdss (L/kg) | 2.1 | - | | Cmax (µM) | - | 1.2 | | t1/2 (h) | 3.5 | 4.1 | | | - | 42% |

Compound is a synthetic small molecule currently in the lead optimization phase. Preliminary data indicates selective inhibition of [hypothetical target: Kinase X or GPCR Y ], with sub-micromolar activity (IC50 = 0.42 µM). CDCL 009 demonstrates favorable metabolic stability (t1/2 > 60 min in human liver microsomes) and low acute toxicity in vitro. This report summarizes its synthesis, characterization, bioactivity, and pharmacokinetic profile. cdcl 009

This has profound implications for the "009" style technical reports on decision-making. It suggests that efficient problem solving is not linear. Effective human teams and effective AI agents must possess the ability to perform "root cause analysis" in real-time, discarding entire branches of wasted effort instantly rather than stepping through them laboriously. | Parameter | IV | PO | |

| Property | Value | Method | | :--- | :--- | :--- | | LogP (predicted) | 2.8 | XLogP3 | | LogD (pH 7.4) | 2.1 | Shake-flask | | Solubility (PBS, pH 7.4) | 125 µg/mL | HPLC-UV | | pKa (strongest acidic) | 9.2 | ACD/Labs | | pKa (strongest basic) | 5.8 | ACD/Labs | | Polar Surface Area (PSA) | 92 Ų | Calculated | | Rotatable bonds | 6 | - | Effective human teams and effective AI agents must